Date of release September 2024

Working group of reference:

WG1. Compound libraries coordination and integration of compound design. (Challenge 1)

Objective: Increase the number of compounds available for the drug research projects that should be screened adopting a coordinated approach (virtually or in phenotypic approaches) to ensure innovation in anti-parasitic drug discovery. Collection and coordination of data and information about compound design.

T1.3 Compounds biodegradability pattern prediction. This can be performed using in silico tool that can provide insight into the chemical degradation of organic compounds under various environmental conditions. (D1.4)

Report on compounds degradability in silico pattern degradation prediction

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi